Amy Jacobs is a pharmacist who is specialized in Ambulatory Care in Dubuque, Iowa. Patients can reach her at 350 N Grandview Ave, Dubuque or contact her on 563-589-2472. Active license number of Amy Jacobs is 21413 for Ambulatory Care in Iowa. Amy Jacobs is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Amy Jacobs speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Amy Jacobs
Specialization:
Ambulatory Care
Gender:
Female
Location:
350 N Grandview Ave, Dubuque, Iowa, 52001-6392
Phone:
563-589-2472
Fax:
563-589-2616
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Amy Jacobs are as mentioned below.
NPI Number:
1508461377
NPI Enumeration Date:
01 Dec, 2020
NPI Last Update On:
01 Dec, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Amy Jacobs are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
21413
Iowa
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1255 S Grandview Ave, Dubuque, Iowa
Zip:
52003-8717
Phone Number:
612-708-5231
Fax Number:
--
Patients can reach Amy Jacobs at 350 N Grandview Ave, Dubuque, Iowa or can call on phone at 563-589-2472.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.